4:持股变动声明-董事 Regan Andrew
SC 13D/A:超过5%持股股东披露文件(修正)-Andrew Regan(31.56%),Corvus Capital Ltd.(31.30%)等
3:首次持股声明-股东 Nirland Ltd
SC 13G/A:超过5%持股股东披露文件(修正)-Nirland Limited(14.8%),Stockton Limited(14.8%)等
4:持股变动声明-董事 Farley Chele Chiavacci
4:持股变动声明-高管 Bligh James
4:持股变动声明-高管 Sragovicz Adam
4:持股变动声明-董事 McNealey Jennifer Isacoff
4:持股变动声明-董事 Farley Chele Chiavacci
4:持股变动声明-董事 Lewis-Hall Freda C
4:持股变动声明-高管 Tapolczay David
Conduit Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Polar Asset Management Partners Inc.(1.3%)
Conduit Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Saba Capital Management, L.P.(0%),Boaz R. Weinstein(0%)等
Conduit Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Hudson Bay Capital Management LP(0.10%),Sander Gerber(0.10%)
Conduit Pharmaceuticals | 4:持股变动声明-董事 Lewis-Hall Freda C
Conduit Pharmaceuticals | 4:持股变动声明-董事 Bligh James
Conduit Pharmaceuticals | 4:持股变动声明-董事 Farley Chele Chiavacci
Conduit Pharmaceuticals | 4:持股变动声明-董事 McNealey Jennifer Isacoff
Conduit Pharmaceuticals | 4:持股变动声明-董事 Charles Faith L.
Conduit Pharmaceuticals | 4:持股变动声明-董事 Tapolczay David
暂无数据
暂无数据